The National Human Rights Commission (NHRC) issued notice to the Delhi government over reported administering of contaminated injections to 20 eye patients at Guru Tegh Bahadur (GTB) Hospital, revealed an NHRC statement.
According to the statement, the notice was issued after the NHRC took suo motu cognizance of a media report that 20 eye patients had to be rushed to the All India Institute of Medical Sciences (AIIMS) from the GTB hospital on April 2 when they complained of blurred vision, pain and watery eyes after they were allegedly administered contaminated injections.
About eight of them reportedly require eye surgery.
"Accordingly, it has issued a notice to the Chief Secretary, Delhi government, calling for a detailed report in the matter within four weeks," the statement said.
The statement said patients, as part of their follow-up treatment, were administered injections containing the drug "Avastian", which is globally used to prevent blindness due to ageing, diabetes, hypertension and rupturing of blood vessels.
"Reportedly, Atul Kumar, Chief of the R.P. Centre for Ophthalmic Sciences at AIIMS, has said that 'Avastian' is classified as sight saving drug and used all over the world. In this case, it seems that the injections were contaminated, which caused the reaction," it said.
According to the statement, the Medical Director of the GTB Hospital has stated that the samples of the injection have been sent to the microbiology lab for testing so that suspected contamination could be determined.
"He has informed that specialists were called immediately when the patients complained about blurred vision and mild pain, during the follow up and the serious cases were referred to the AIIMS," the statement added.